INS and glucose metabolism disease: On the basis of previous studies and our present findings, it can be deduced that the enhanced TAK1–MKK–JNK activation by hepatic TRAF3 might be, at least partly, responsible for the TRAF3-regulated exacerbation of insulin dysfunction, glucose metabolic disorder and fatty acid accumulation in the liver.